These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13891882)

  • 41. The effect of human serum albumin and mercurial diuretics on ascites in patients with hepatic cirrhosis.
    HAVENS WP; BLUEMLE LW
    Gastroenterology; 1950 Oct; 16(2):455-65. PubMed ID: 14778480
    [No Abstract]   [Full Text] [Related]  

  • 42. Gastro-intestinal manifestations of bilharzial cirrhosis with special reference to the pyloro-duodenal region.
    FAYEZ M; ABDEL-KHALEK K
    J Egypt Med Assoc; 1962; 45():23-36. PubMed ID: 13891881
    [No Abstract]   [Full Text] [Related]  

  • 43. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
    Inoue J; Mori Y; Kawamura T
    Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
    [No Abstract]   [Full Text] [Related]  

  • 44. Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Klein S; Rick J; Lehmann J; Schierwagen R; Schierwagen IG; Verbeke L; Hittatiya K; Uschner FE; Manekeller S; Strassburg CP; Wagner KU; Sayeski PP; Wolf D; Laleman W; Sauerbruch T; Trebicka J
    Gut; 2017 Jan; 66(1):145-155. PubMed ID: 26385087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between the degree of portal hypertension and the onset of spontaneous bacterial peritonitis in patients with cirrhosis.
    Sersté T; Bourgeois N; Lebrec D; Evrard S; Devière J; Le Moine O
    Acta Gastroenterol Belg; 2006; 69(4):355-60. PubMed ID: 17343075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein content of thoracic duct lymph in patients with bilharzial hepatic fibrosis.
    El-Zawahry MD; El-Roubi OA; Ibrahim AS
    Gastroenterology; 1977 Apr; 72(4 Pt 1):617-20. PubMed ID: 838214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EXPERIMENTAL ASCITES. VI. THE EFFECTS OF HEPATIC VENOUS OUTFLOW OBSTRUCTION AND ASCITES ON ALDOSTERONE SECRETION.
    ORLOFF MJ; ROSS TH; BADDELEY RM; NUTTING RO; SPITZ BR; SLOOP RD; NEESBY T; HALASZ NA
    Surgery; 1964 Jul; 56():83-98. PubMed ID: 14174755
    [No Abstract]   [Full Text] [Related]  

  • 49. Steatosis and portal hypertension.
    Puoti C; Bellis L
    Eur Rev Med Pharmacol Sci; 2005; 9(5):285-90. PubMed ID: 16231591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRIAMTERENE IN THE TREATMENT OF ASCITES IN HEPATIC CIRRHOSIS.
    TURNER P; SOWRY GS
    Br J Clin Pract; 1964 Jan; 18():13-7. PubMed ID: 14114540
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Therapeutic schemes for refractory ascites of advanced schistosomiasis: a clinical control study].
    He HR; Li M; Wei DP; Zhu JJ; Yang JB; Feng XH; Din W; Zhou RB; Lu GZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Oct; 24(5):570-2. PubMed ID: 23373268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [CONSIDERATIONS ON THE USE OF THIAZIDE DIURETICS IN THE TREATMENT OF ASCITIC HEPATIC CIRRHOSIS].
    DEPASQUALE C; DIMODICA G; SCIVERES G
    Sicil Sanit; 1964; 17():23-8. PubMed ID: 14249627
    [No Abstract]   [Full Text] [Related]  

  • 54. [Is diuretic-resistant ascites reversible in patients with liver cirrhosis amd portal hypertension?].
    Mansurov AA; Nazyrov FG; Akilov KhA; Ibadov RA; Karimov USh
    Klin Khir; 1998; (11):48-9. PubMed ID: 10077928
    [No Abstract]   [Full Text] [Related]  

  • 55. [Research on ascites in schistosomal hepatic cirrhosis].
    EL-GHAFFAR YA
    Epatologia; 1963; 9():19-29. PubMed ID: 13960604
    [No Abstract]   [Full Text] [Related]  

  • 56. Observations on portal venous pressure following hepatic artery ligation in experimental animals.
    CALDWELL RS; FITCHETT CW; LEHMAN EP; MORTON CB
    Surgery; 1954 Dec; 36(6):1068-74. PubMed ID: 13216495
    [No Abstract]   [Full Text] [Related]  

  • 57. [OBSERVATIONS ON THE CLINICAL USE OF TRIAMTERENE IN TREATMENT OF THE ASCITES OF HEPATIC CIRRHOSIS].
    BORRELLI PL; CAIRELLA M; DEMARTIIS M
    Clin Ter; 1964 Jun; 29():471-5. PubMed ID: 14173216
    [No Abstract]   [Full Text] [Related]  

  • 58. The aetiology and management of ascites in patients with hepatic cirrhosis: a review.
    SHERLOCK S; SHALDON S
    Gut; 1963 Jun; 4(2):95-105. PubMed ID: 13977164
    [No Abstract]   [Full Text] [Related]  

  • 59. Serum and ascitic fluid lactic dehydrogenase in bilharzial (schistosomal) hepatic fibrosis.
    Ghanem MH; Guirgis FK; el-Sawy M
    J Trop Med Hyg; 1970 Oct; 73(10):240-4. PubMed ID: 5478039
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of tense ascites onthe portal venous pressure and its relation to the development of haematemesis.
    FAVEZ M; AZIZ S
    J Egypt Med Assoc; 1961; 44():758-66. PubMed ID: 13891857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.